Zobrazeno 1 - 10
of 766
pro vyhledávání: '"Hartry A"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 11, Pp 741-755 (2019)
Arpamas Seetasith,1 Mallik Greene,2 Ann Hartry,3 Chakkarin Burudpakdee1 1Medical and Scientific Services, Real-World Evidence Solutions, IQVIA, Falls Church, VA 22042, USA; 2Health Economics and Outcomes Research, Otsuka Pharmaceutical Development An
Externí odkaz:
https://doaj.org/article/635ec60fb4a14fd5b1f532147c23f394
Autor:
Dana B. DiBenedetti, Heather Menne, Russ Paulsen, Holly B. Krasa, George Vradenburg, Meryl Comer, Leigh F. Callahan, John Winfield, Michele Potashman, Kim Heithoff, Ann Hartry, Dorothee Oberdhan, Hilary Wilson, Deborah L. Hoffman, Dan Wieberg, Ian N. Kremer, Geraldine A. Taylor, James M. Taylor, Debra Lappin, Allison D. Martin, Brett Hauber, Carla Romano
Publikováno v:
Neurology and Therapy, Vol 12, Iss 2, Pp 571-595 (2023)
Abstract Introduction Insight into the relationship between concepts that matter to the people affected by Alzheimer’s disease (AD) and the clinical outcome assessments (COAs) commonly used in AD clinical studies is limited. Phases 1 and 2 of the W
Externí odkaz:
https://doaj.org/article/4563c68c02c441bda9571595e1d88641
Autor:
Brett Hauber, Russ Paulsen, Holly B. Krasa, George Vradenburg, Meryl Comer, Leigh F. Callahan, John Winfield, Michele Potashman, Ann Hartry, Daniel Lee, Hilary Wilson, Deborah L. Hoffman, Dan Wieberg, Ian N. Kremer, Geraldine A. Taylor, James M. Taylor, Debra Lappin, Allison D. Martin, Terry Frangiosa, Virginia Biggar, Christina Slota, Carla Romano, Dana B. DiBenedetti
Publikováno v:
Neurology and Therapy, Vol 12, Iss 2, Pp 505-527 (2023)
Abstract Introduction In this phase of the ongoing What Matters Most study series, designed to evaluate concepts that are meaningful to people affected by Alzheimer’s disease (AD), we quantified the importance of symptoms, impacts, and outcomes of
Externí odkaz:
https://doaj.org/article/3e5b9fbbd452432f931fe5334ada2652
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 15, Iss 4, Pp n/a-n/a (2023)
Abstract INTRODUCTION Understanding the prevalence of treatment‐eligible Alzheimer's disease (AD) is crucial for policy planning. METHODS We used a comprehensive literature review and population cascade approach to estimate the number of amyloid‐
Externí odkaz:
https://doaj.org/article/b0bec83da8a94ded963dbec1458c52a5
Autor:
Field, Hartry
Publikováno v:
Proceedings and Addresses of the American Philosophical Association, 2019 Nov 01. 93, 140-157.
Externí odkaz:
https://www.jstor.org/stable/45222981
Autor:
Broder, Michael S., Greene, Mallik, Yan, Tingjian, Chang, Eunice, Hartry, Ann, Yermilov, Irina
Publikováno v:
In Clinical Therapeutics February 2019 41(2):221-232
Autor:
Cloutier, Martin, Gauthier-Loiselle, Marjolaine, Gagnon-Sanschagrin, Patrick, Guerin, Annie, Hartry, Ann, Baker, Ross A., Duffy, Ruth, Gwin, Keva, Sanon Aigbogun, Myrlene
Publikováno v:
In Alzheimer's & Dementia: Translational Research & Clinical Interventions 2019 5:851-861
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Broder, Michael S., Greene, Mallik, Chang, Eunice, Hartry, Ann, Touya, Maëlys, Munday, Jennifer, Yan, Tingjian
Publikováno v:
In Clinical Therapeutics October 2018 40(10):1670-1682
Autor:
Hartry, Ann, Aldhouse, Natalie V.J., Al-Zubeidi, Tamara, Sanon, Myrlene, Stefanacci, Richard G., Knight, Sarah L.
Publikováno v:
In Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2018 10:498-508